204 related articles for article (PubMed ID: 33189529)
1. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
Maroto P; García Del Muro X; Valverde C; Pinto A; Sanchez A; Guma J; Alonso T; Martínez Del Prado P; Vazquez S; Mellado B; Aparicio J; Fernandez-Aramburo A; Girones R; Terrasa J;
Urol Oncol; 2021 Feb; 39(2):135.e17-135.e23. PubMed ID: 33189529
[TBL] [Abstract][Full Text] [Related]
2. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
3. Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients.
Akdogan B; Divrik RT; Tombul T; Yazici S; Tasar C; Zorlu F; Ozen H
J Urol; 2007 Jul; 178(1):129-33; discussion 133. PubMed ID: 17499297
[TBL] [Abstract][Full Text] [Related]
4. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years.
Watson RA; Morgan RD; Joseph J; Sivakumar S; Verrill C; Tuthill M; Sullivan M; Protheroe AS
Clin Genitourin Cancer; 2018 Jun; 16(3):e513-e516. PubMed ID: 29566999
[No Abstract] [Full Text] [Related]
6. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era.
Park DS; Prow DM; Amato RJ; Ro JY; Logothetis CJ
Yonsei Med J; 1999 Apr; 40(2):137-43. PubMed ID: 10333717
[TBL] [Abstract][Full Text] [Related]
8. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract][Full Text] [Related]
9. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
10. Bilateral testicular germ cell tumours: a single hospital experience.
Morales-Barrera R; Valverde C; Rodón J; Pérez J; Maldonado X; Suárez C; Trilla E; Carles J
Clin Transl Oncol; 2010 Apr; 12(4):299-302. PubMed ID: 20462840
[TBL] [Abstract][Full Text] [Related]
11. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
[TBL] [Abstract][Full Text] [Related]
12. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007).
Andreassen KE; Grotmol T; Cvancarova MS; Johannesen TB; Fosså SD
Int J Cancer; 2011 Dec; 129(12):2867-74. PubMed ID: 21626506
[TBL] [Abstract][Full Text] [Related]
13. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
14. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
[TBL] [Abstract][Full Text] [Related]
15. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
[TBL] [Abstract][Full Text] [Related]
16. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984.
Osterlind A; Berthelsen JG; Abildgaard N; Hansen SO; Hjalgrim H; Johansen B; Munck-Hansen J; Rasmussen LH
J Natl Cancer Inst; 1991 Oct; 83(19):1391-5. PubMed ID: 1656057
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
18. Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.
Hentrich M; Weber N; Bergsdorf T; Liedl B; Hartenstein R; Gerl A
Acta Oncol; 2005; 44(6):529-36. PubMed ID: 16165911
[TBL] [Abstract][Full Text] [Related]
19. Incidence of contralateral germ cell testicular tumors in South Europe: report of the experience at 2 Spanish university hospitals and review of the literature.
Tabernero J; Paz-Ares L; Salazar R; Lianes P; Guerra J; Borrás J; Villavicencio H; Leiva O; Cortés-Funes H
J Urol; 2004 Jan; 171(1):164-7. PubMed ID: 14665868
[TBL] [Abstract][Full Text] [Related]
20. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Kvammen Ø; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
J Clin Oncol; 2021 Feb; 39(4):308-318. PubMed ID: 33356420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
